Cite

HARVARD Citation

    Bono, P. et al. (n.d.). 420PPhase I/II study of ODM-203, a selective dual FGFR/VEGFR inhibitor, in patients with advanced solid tumours. Annals of oncology. p. . [Online]. 
  
Back to record